The next biotech boom could begin with the mental health crisis

Opinion: Psychedelic therapies are moving from scientific margins toward mainstream biotechnology as researchers search for better treatments for severe psychiatric disorders; The opportunity is significant, but so are the clinical, regulatory and financial risks

Raccontata daynetnews.com